177Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine Neoplasms
Clinical trial NCT01237457 · COMPLETED
Trial details
- NCT number
- NCT01237457
- Sponsor
- Ebrahim S Delpassand
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-27
- Primary completion
- 2016-11-17
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.